Variant report
Variant | esv3366608 |
---|---|
Chromosome Location | chr3:150747837-150750135 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs539110928 | chr3:150749219-150749220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs555846480 | chr3:150749329-150749330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs138609420 | chr3:150749335-150749336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368355901 | chr3:150749372-150749373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140286758 | chr3:150749373-150749374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs189252122 | chr3:150749376-150749377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs181093280 | chr3:150749402-150749403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184201197 | chr3:150749413-150749414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189024532 | chr3:150749433-150749434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs181750785 | chr3:150749439-150749440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs9867145 | chr3:150749446-150749447 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs533179311 | chr3:150749469-150749470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs374874821 | chr3:150749585-150749586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs535493468 | chr3:150749588-150749589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs535851303 | chr3:150749669-150749670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542083848 | chr3:150749704-150749705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146614178 | chr3:150749731-150749732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs112707156 | chr3:150749740-150749741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562973908 | chr3:150749746-150749747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs137914505 | chr3:150749759-150749760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs186367534 | chr3:150749761-150749762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs116347252 | chr3:150749789-150749790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs527955554 | chr3:150749837-150749838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs374132105 | chr3:150749849-150749850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs111471130 | chr3:150749936-150749937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs570668356 | chr3:150750027-150750028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149444608 | chr3:150750087-150750088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs115654866 | chr3:150750099-150750100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21364760 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 16773561 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20605837 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:150749200-150750000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr3:150750000-150753200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |